Earlier this week, Sheikh Mohammed bin Rashid, Vice President and Ruler of Dubai, encouraged all citizens and residents of the UAE to get vaccinated against Covid-19 to "help us end this pandemic". By personally encouraging people to do so, the country's leadership is making clear the direct line between inoculation and speeding up the nation's post-pandemic recovery. It also highlights that UAE public officials believe that an end to Covid-19's grip on our lives – at least in the Emirates – is in sight.
Herd immunity is the ultimate goal. As of Tuesday, 1,275,500 shots have been administered in the UAE, putting the country second globally in the number of vaccines administered for every 100 people. Any adult residing in the country is able to get the vaccine for free. Sheikh Mohamed bin Zayed, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the Armed Forces said that “we hope that with vaccinations picking up pace, we will reach the point of full recovery in the shortest possible time”. That is the hope we all share and for which we must strive.
Yet, the projected pace of progress in an individual nation does not match global rates.
On Monday, the World Health Organisation warned that worldwide herd immunity would not be achieved by the end of 2021. Surging infection rates across Europe form part of this estimation. Other reasons given by the UN agency's chief scientist, Soumya Swaminathan, include limited access to vaccines in developing countries, false scepticism some hold over vaccine safety, and the threat posed by the virus mutating into more contagious forms, possibly ones that render vaccines less effective.
Al Aweer desert farms in Dubai emirate, which due to Covid-19 has cultivated the desert to provide crops and reduce imports. AFP
Vaccination rollouts do not mean the fight against Covid-19 is over
The statement stressed that any inoculation programme takes time. Nonetheless, many governments who knew even in the early days of the pandemic that vaccines would come failed to prepare logistically for a swift rollout. There has also been a global inability to develop strategies to keep up pace with misinformation and conspiracy theories about the safety of jabs.
The speed of vaccine development during this pandemic has been unprecedented. But this win does not guard against inevitable setbacks. Yesterday, researchers in Brazil published a study showing that the CoronoVac shot, a mainstay of the country's inoculation programme, is only 50 per cent effective.
Even in nations ahead on vaccination, cases are rising. Israel, which leads the field in inoculating its citizens, is experiencing a surge in infections that it blames on the arrival of the more infectious UK variant of Covid-19 in the country. On Tuesday, the UAE recorded 3,243 new cases of the virus, the first time since the beginning of the pandemic that the nation exceeded 3,000 daily cases. While this number is significantly lower than in other developed countries, it highlights the fact that the acceleration of vaccination campaigns does not yet mean the fight against Covid-19 is over.
Stressing this simple point consistently should remain central in public messaging the world over. Even in nations where herd immunity in 2021 remains possible, people must not lose discipline and jeopardise recent progress. Hand-washing, maintaining social distancing and wearing face masks in public remain as important as they were at the beginning of the pandemic.
1. Kylian Mbappe - to Real Madrid in 2017/18 - €180 million (Dh770.4m - if a deal goes through)
2. Paul Pogba - to Manchester United in 2016/17 - €105m
3. Gareth Bale - to Real Madrid in 2013/14 - €101m
4. Cristiano Ronaldo - to Real Madrid in 2009/10 - €94m
5. Gonzalo Higuain - to Juventus in 2016/17 - €90m
6. Neymar - to Barcelona in 2013/14 - €88.2m
7. Romelu Lukaku - to Manchester United in 2017/18 - €84.7m
8. Luis Suarez - to Barcelona in 2014/15 - €81.72m
9. Angel di Maria - to Manchester United in 2014/15 - €75m
10. James Rodriguez - to Real Madrid in 2014/15 - €75m
Tour de France
When: July 7-29
UAE Team Emirates:
Dan Martin, Alexander Kristoff, Darwin Atapuma, Marco Marcato, Kristijan Durasek, Oliviero Troia, Roberto Ferrari and Rory Sutherland
Specs
Engine: 3.0L twin-turbo V6 Gearbox: 10-speed automatic Power: 405hp at 5,500rpm Torque: 562Nm at 3,000rpm Fuel economy, combined: 11.2L/100km Price: From Dh292,845 (Reserve); from Dh320,145 (Presidential) On sale: Now
Thalassaemia is part of a family of genetic conditions affecting the blood known as haemoglobin disorders.
Haemoglobin is a substance in the red blood cells that carries oxygen and a lack of it triggers anemia, leaving patients very weak, short of breath and pale.
The most severe type of the condition is typically inherited when both parents are carriers. Those patients often require regular blood transfusions - about 450 of the UAE's 2,000 thalassaemia patients - though frequent transfusions can lead to too much iron in the body and heart and liver problems.
The condition mainly affects people of Mediterranean, South Asian, South-East Asian and Middle Eastern origin. Saudi Arabia recorded 45,892 cases of carriers between 2004 and 2014.
A World Health Organisation study estimated that globally there are at least 950,000 'new carrier couples' every year and annually there are 1.33 million at-risk pregnancies.
US tops drug cost charts
The study of 13 essential drugs showed costs in the United States were about 300 per cent higher than the global average, followed by Germany at 126 per cent and 122 per cent in the UAE.
Thailand, Kenya and Malaysia were rated as nations with the lowest costs, about 90 per cent cheaper.
In the case of insulin, diabetic patients in the US paid five and a half times the global average, while in the UAE the costs are about 50 per cent higher than the median price of branded and generic drugs.
Some of the costliest drugs worldwide include Lipitor for high cholesterol.
The study’s price index placed the US at an exorbitant 2,170 per cent higher for Lipitor than the average global price and the UAE at the eighth spot globally with costs 252 per cent higher.
High blood pressure medication Zestril was also more than 2,680 per cent higher in the US and the UAE price was 187 per cent higher than the global price.